Related references
Note: Only part of the references are listed.Targeting of drugs and nanoparticles to tumors
Erkki Ruoslahti et al.
JOURNAL OF CELL BIOLOGY (2010)
Integrins in cancer: biological implications and therapeutic opportunities
Jay S. Desgrosellier et al.
NATURE REVIEWS CANCER (2010)
Tissue-Penetrating Delivery of Compounds and Nanoparticles into Tumors
Kazuki N. Sugahara et al.
CANCER CELL (2009)
Is Anticancer Drug Development Heading in the Right Direction?
Trevor W. Hambley
CANCER RESEARCH (2009)
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Tambet Teesalu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Systematic Surface Engineering of Magnetic Nanoworms for in vivo Tumor Targeting
Ji-Ho Park et al.
SMALL (2009)
Neuropilins: structure, function and role in disease
Caroline Pellet-Many et al.
BIOCHEMICAL JOURNAL (2008)
Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor
Lisette M. Acevedo et al.
BLOOD (2008)
The role of doxorubicin and epirubicin in the treatment of patients with metastatic hormone-refractory prostate cancer
Roberto Petrioli et al.
CANCER TREATMENT REVIEWS (2008)
Enhanced Antitumor Efficacy of Clinical-Grade Vasculature-Targeted Liposomal Doxorubicin
Fabio Pastorino et al.
CLINICAL CANCER RESEARCH (2008)
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Eric A. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Drug penetration in solid tumours
Andrew I. Minchinton et al.
NATURE REVIEWS CANCER (2006)
Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor Exon 8 for NP-1 binding and role of NP-1 in KDR signaling
HY Jia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Applications of major histocompatibility complex class I molecules expressed as single chains
T Primeau et al.
IMMUNOLOGIC RESEARCH (2005)
Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications
H Maeda et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis
JA Joyce et al.
CANCER CELL (2003)
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma
JA Hoffman et al.
CANCER CELL (2003)
A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo
K Porkka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
